trans-4-(Aminomethyl)cyclohexanecarboxylic acid

CAS : 1197-17-7

Ref. 3D-IA71533

Informations sur le produit

• Nom: trans-4-(Aminomethyl)cyclohexanecarboxylic acid
• Synonymes: Tranexamic acid impurity Bcis-Tranexamic acid
• Marque: Biosynth
• Description: Trans-4-(aminomethyl)cyclohexanecarboxylic acid (AMCA) is a histamine antagonist that is used to treat bowel disease. It may also be useful for the treatment of other inflammatory diseases and as an anticoagulant. AMCA has been shown to be safe and effective for the prevention of postoperative bleeding in patients who are undergoing major surgery. This drug is a potent inhibitor of platelet aggregation, but does not affect the function of erythrocytes or leukocytes. AMCA inhibits platelet aggregation by blocking the binding of adenosine diphosphate (ADP) to its receptor on platelets, thus inhibiting ADP-mediated activation of phospholipase A2 and arachidonic acid release from membranes. An increase in blood levels of AMCA may lead to cardiac toxicity and bleeding events.

Propriétés chimiques

• Masse moléculaire: 157.21 g/mol
• Formule: C₈H₁₅NO₂
• Degré de pureté: Min. 95%
• InChI: InChI=1S/C8H15NO2/c9-5-6-1-3-7(4-2-6)8(10)11/h6-7H,1-5,9H2,(H,10,11)
• Code InChI: InChIKey=GYDJEQRTZSCIOI-UHFFFAOYSA-N
• SMILES: NCC1CCC(C(=O)O)CC1